EUCTR2005-000710-12-DK进行中(未招募)1 期
Smertebehandling af børn i skadestuen med Actiq
Aalborg Sygehus0 个研究点目标入组 20 人开始时间: 2005年5月2日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Alder 3-12 år
- •- Vægt 15-40 kg
- •- Traume, hvor behandlingen omfatter en smertevoldende procedure og hvor barnet hjemsendes efter endt behandling.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Hovedtraume
- •- Påvirket almentilstand
- •- Hjerte- lungesygdom
- •- Kendt allergi overfor Fentanyl
研究者
相似试验
进行中(未招募)
不适用
Irinotecan singele drug treatment for children with refractory or relapsed hepatoblastomaRefractory or recurrent hepatoblastomaEUCTR2005-002925-29-ATniversity Childrens Hospital30
招募中
不适用
Follow-up of infants and children surgically treated for an acquired laryngeal stenosis after endotracheal intubatioverworven luchtwegaandoeningenlarynxstenosisnarrowing of the upper airwayNL-OMON34296Erasmus MC, Universitair Medisch Centrum Rotterdam79
已完成
3 期
S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Vascular Access Procedures in ChildrenPainNCT00125255ZARS Pharma Inc.81
尚未招募
4 期
Topical Amethocaine versus Topical Eutectic Mixture of Local Anaesthetic (EMLA)Intravenous cannulation in childrenAnaesthesiology - AnaestheticsACTRN12606000409572Auckland District Health Board660
进行中(未招募)
1 期
Traitement précoce de patients pédiatriques présentant un syndrome hémolytique et urémique typique par l’anticorps monoclonal anti-C5 eculizumab : essai thérapeutique prospectif randomisé contrôlé contre placebo de phase IIIHemolytic and uremic syndromeMedDRA version: 17.0 Level: LLT Classification code 10042814 Term: Syndrome hemolytic uremic System Organ Class: 100000004851EUCTR2014-001169-28-FRCentre Hospitalier de Toulouse100
